These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1335948)
1. Epstein-Barr virus-transformed B lymphocytes produce low molecular mass molecules with autocrine growth factor and competence factor activity. Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M; Falcone G FEMS Microbiol Lett; 1992 Dec; 100(1-3):449-54. PubMed ID: 1335948 [TBL] [Abstract][Full Text] [Related]
2. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. Tosato G; Tanner J; Jones KD; Revel M; Pike SE J Virol; 1990 Jun; 64(6):3033-41. PubMed ID: 2159561 [TBL] [Abstract][Full Text] [Related]
3. Density-dependent responsiveness to autocrine growth factors of Epstein-Barr virus transformed human B lymphocytes. Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M Microbiologica; 1992 Jul; 15(3):303-7. PubMed ID: 1501588 [TBL] [Abstract][Full Text] [Related]
4. Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1. Blazar BA; Murphy AM Clin Exp Immunol; 1990 Apr; 80(1):62-8. PubMed ID: 2157568 [TBL] [Abstract][Full Text] [Related]
5. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979 [TBL] [Abstract][Full Text] [Related]
6. Activity of soluble factors produced by Epstein-Barr virus-transformed human B lymphocytes on different cell lines. Garzelli C; Bazzichi A Experientia; 1991 Jul; 47(7):731-4. PubMed ID: 1648507 [TBL] [Abstract][Full Text] [Related]
7. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Wakasugi H; Rimsky L; Mahe Y; Kamel AM; Fradelizi D; Tursz T; Bertoglio J Proc Natl Acad Sci U S A; 1987 Feb; 84(3):804-8. PubMed ID: 3027706 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes. Baumann MA; Paul CC Blood; 1992 Apr; 79(7):1763-7. PubMed ID: 1313713 [TBL] [Abstract][Full Text] [Related]
11. The role of lactic acid in autocrine B-cell growth stimulation. Pike SE; Markey SP; Ijames C; Jones KD; Tosato G Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11081-5. PubMed ID: 1662382 [TBL] [Abstract][Full Text] [Related]
12. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells. Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line. Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138 [TBL] [Abstract][Full Text] [Related]
14. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus. Blazar BA; Sutton LM; Strome M Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371 [TBL] [Abstract][Full Text] [Related]
15. [Interleukin-1-like factor from human B-lymphocytes transformed by the Epstein-Barr virus]. Kotov AIu; Simbirtsev AS; Perumov ND; Ketlinskiĭ SA Tsitologiia; 1989 Feb; 31(2):226-33. PubMed ID: 2544049 [TBL] [Abstract][Full Text] [Related]
16. Capacity of B-lymphocytic lines of diverse tumor origin to produce and respond to B-cell growth factors: a progression model for B-cell lymphomagenesis. Gordon J; Aman P; Rosén A; Ernberg I; Ehlin-Henriksson B; Klein G Int J Cancer; 1985 Feb; 35(2):251-6. PubMed ID: 2982745 [TBL] [Abstract][Full Text] [Related]
17. Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells. Gee K; Kozlowski M; Kryworuchko M; Diaz-Mitoma F; Kumar A Cell Immunol; 2001 Aug; 211(2):131-42. PubMed ID: 11591117 [TBL] [Abstract][Full Text] [Related]
18. Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis. Gordon J; Guy G; Walker L; Nathan P; Exley R; Clemens M Med Oncol Tumor Pharmacother; 1986; 3(3-4):269-73. PubMed ID: 3027466 [TBL] [Abstract][Full Text] [Related]
19. Effect of Escherichia-coli thioredoxin, a homolog to the adult T-cell leukemia-derived factor, on epstein-barr virus-transformed B-lymphocytes. Bazzichi A; Incaprera M; Garzelli C Int J Oncol; 1994 Jul; 5(1):41-6. PubMed ID: 21559555 [TBL] [Abstract][Full Text] [Related]
20. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines. Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]